PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 297 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 9.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $546,319 | -63.8% | 17,807 | -51.9% | 0.00% | -83.3% |
| Q1 2023 | $1,510,378 | -25.8% | 37,010 | -29.8% | 0.01% | -45.5% |
| Q4 2022 | $2,034,901 | +46.9% | 52,704 | +121.9% | 0.01% | +10.0% |
| Q2 2022 | $1,385,000 | +195.3% | 23,754 | +204.6% | 0.01% | +150.0% |
| Q4 2021 | $469,000 | -2.3% | 7,798 | -9.0% | 0.00% | -33.3% |
| Q3 2021 | $480,000 | -8.0% | 8,566 | -0.4% | 0.01% | 0.0% |
| Q2 2021 | $522,000 | +56.8% | 8,598 | +81.2% | 0.01% | +20.0% |
| Q1 2021 | $333,000 | -55.7% | 4,746 | -66.9% | 0.01% | -54.5% |
| Q2 2020 | $752,000 | +23.9% | 14,329 | +6.9% | 0.01% | -42.1% |
| Q4 2019 | $607,000 | – | 13,402 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |